Comparison of clinical outcomes of toric intraocular lens, Precizon vs Tecnis: a single center randomized controlled trial

Clicks: 340
ID: 274552
2018
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #4 of 6 articles by views in bmc ophthalmology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
http://clinicaltrials.gov , NCT03085901 , retrospectively registered on 21 March 2017.
Reference Key
ny2018bmccomparison Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Jung NY;Lim DH;Hwang SS;Hyun J;Chung TY;;
Journal bmc ophthalmology
Year 2018
DOI
DOI not found
URL
https://www.pubmed.gov/30413154/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome adult female male aged middle aged young adult Comparative Study Prospective Studies Visual Acuity / physiology* 80 and over Vision Tests Randomized Controlled Trial Double-Blind Method Astigmatism / physiopathology Lens Implantation Intraocular* Lenses prosthesis design refraction ocular cataract / complications astigmatism / complications phacoemulsification* pmid:30413154 pmc6230282 doi:10.1186/s12886-018-0955-3 na yeon jung dong hui lim tae-young chung biometry cataract / physiopathology pseudophakia / physiopathology*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.